Login/Sign Up
Dynaglipt L Tablet is an anti-diabetic medication primarily used to treat type 2 diabetes in adults along with diet and lifestyle changes. It is used alone or in combination with other drugs to lower blood sugar levels. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes, also known as adult-onset diabetes.
Dynaglipt L Tablet contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Dynaglipt L Tablet is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone 'Incretin'). The enzyme 'Incretins' helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Dynaglipt L Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.
Take Dynaglipt L Tablet as prescribed. However, it should be taken at the same time of the day each time for best results. Your doctor will recommend you how often you take Dynaglipt L Tablet based on your medical condition. The most common side effects of Dynaglipt L Tablet are hypoglycaemia (low blood glucose levels), upper respiratory tract infection, nasopharyngitis (infection of nose and throat with common cold), and headache.
Dynaglipt L Tablet should not be stopped even if you feel better, without consulting your doctor as sugar level keeps changing. If you stop taking Dynaglipt L Tablet abruptly, it may increase your sugar levels, which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Dynaglipt L Tablet should not be taken if you have severe kidney or liver disease. Please inform your doctor if you have any heart disease is or planning to get pregnant or breastfeeding.
Dynaglipt L Tablet is primarily used to treat Type 2 diabetes mellitus. It contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Dynaglipt L Tablet is prescribed for type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Dynaglipt L Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis. Thus, Dynaglipt L Tablet plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer and delayed wound healing.
Dynaglipt L Tablet should not be taken if you are allergic to Dynaglipt L Tablet or any of its ingredients. Please inform your doctor if you are pregnant or breastfeeding before starting Dynaglipt L Tablet . Prolonged intake of Dynaglipt L Tablet may cause acute pancreatitis (swollen pancreas), and critical kidney problem. Increased risk of hypoglycaemia (low blood sugar level) can occur when Dynaglipt L Tablet is added to other anti-diabetic agents or insulin therapy. In this case, your doctor may adjust the dose of Dynaglipt L Tablet . Severe allergic reactions might occur in some patients taking Dynaglipt L Tablet like anaphylaxis, angioedema (swelling under the skin), and exfoliative skin conditions including Stevens-Johnson syndrome. Safety and efficacy of Dynaglipt L Tablet in children under 18 years have not been established, so it should not be given to them. Patients taking digoxin (a heart medicine) with Dynaglipt L Tablet should be closely monitored as severe drug interaction has been observed. Dynaglipt L Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.
Drug-Drug Interactions: Dynaglipt L Tablet interacts with heart condition drugs (digoxin), diuretic (furosemide), steroids (budesonide), antibiotic (rifampin), anti-epileptic drugs (phenytoin, topiramate, lamotrigine), heart-related chest medicine (ranolazine), Beta-blocker medications ( metoprolol, propranolol, glaucoma eye drops such as timolol) insulin, and other antidiabetic medicines.
Drug-Food Interactions: Intake of excessive alcoholic beverages may increase the chance of a life-threatening condition known as Lactic Acidosis. So, avoid intake of alcoholic beverages with Dynaglipt L Tablet . Also, inform your doctor if you are taking St. John's wort (a natural remedy for depression).
Drug-Disease Interactions: Dynaglipt L Tablet may interact if taken in heart problems, high triglycerides (a type of fat in the blood), pancreatitis, gallstones, alcoholism, and kidney problem.
Diabetes (Type 2): It is a condition where the body cannot make sufficient insulin, or the insulin that it makes doesn't work properly or is utilized by our body. This can cause high blood sugar levels (hyperglycemia). Type 2 diabetes symptoms include increased thirst, frequent urination at night, slow wound healing, increased hunger, fatigue, and blurred vision. There may be weight gain in some cases, while in rare cases, weight loss may be observed. The complication of type 2 diabetes also includes neuropathy (nerve problems), nephropathy (kidney problems), and retinopathy (damaged retina of eyes or blindness), loss of limbs, sexual dysfunction, and increase the chance of heart attack or stroke.
About Dynaglipt L Tablet
Dynaglipt L Tablet is an anti-diabetic medication primarily used to treat type 2 diabetes in adults along with diet and lifestyle changes. It is used alone or in combination with other drugs to lower blood sugar levels. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes, also known as adult-onset diabetes.
Dynaglipt L Tablet contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Dynaglipt L Tablet is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone 'Incretin'). The enzyme 'Incretins' helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Dynaglipt L Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.
Take Dynaglipt L Tablet as prescribed. However, it should be taken at the same time of the day each time for best results. Your doctor will recommend you how often you take Dynaglipt L Tablet based on your medical condition. The most common side effects of Dynaglipt L Tablet are hypoglycaemia (low blood glucose levels), upper respiratory tract infection, nasopharyngitis (infection of nose and throat with common cold), and headache.
Dynaglipt L Tablet should not be stopped even if you feel better, without consulting your doctor as sugar level keeps changing. If you stop taking Dynaglipt L Tablet abruptly, it may increase your sugar levels, which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Dynaglipt L Tablet should not be taken if you have severe kidney or liver disease. Please inform your doctor if you have any heart disease is or planning to get pregnant or breastfeeding.
₹74.3*
MRP ₹82.5
10% off
₹70.12*
MRP ₹82.5
15% CB
₹12.38 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Available Offers
Country of origin
Manufacturer/Marketer address
Dynaglipt L Tablet contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Dynaglipt L Tablet is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Dynaglipt L Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.
Type 2 diabetes is a common form of diabetes. The body cannot make a sufficient amount of insulin and the body's insulin does not function properly. The blood glucose level increases, and symptoms such as frequent urination, increased thirst, and increased hunger . Diabetes, if left untreated or not treated properly, can cause long-term complications like nerve damage, kidney damage, eye damage, foot problems, and fall under a higher risk of developing heart diseases.
Hypoglycemia refers to low blood sugar levels. Dynaglipt L Tablet can cause hypoglycemia. The symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness. Hypoglycemia can occur if you miss or delay your food, drink alcohol, over-exercise or take other antidiabetic medicine along with this medicine. People with diabetes are advised to keep a quick sugar source like glucose tablets, honey or fruit juice.
Dynaglipt L Tablet should be avoided in patients who are allergic to any of this medicine's components or excipients. It should be avoided in patients suffering from moderate to severe kidney disease and in patients with underlying metabolic acidosis, including diabetic ketoacidosis, consult your doctor for further advice.
No. Dynaglipt L Tablet is only prescribed to treat type 2 diabetes, also called 'non-insulin-dependent diabetes.'
In type 1 diabetes, cells in the pancreas that make insulin are destroyed, and the body is unable to make insulin. Insulin is a hormone that helps your body's cells use glucose for energy. The condition is usually diagnosed in children and young people, so it used to be called juvenile diabetes.
Customers Also Bought
Alcohol
Unsafe
Alcohol should not be consumed along with Dynaglipt L Tablet as it is known to interact and lead to unpleasant side effects.
Pregnancy
Caution
Dynaglipt L Tablet is a category B pregnancy medication. So, its safety in pregnant women is not established. So, it should be taken only if prescribed by a doctor.
Breast Feeding
Caution
It is not known whether Dynaglipt L Tablet passes through the breast milk or not. So, it should be taken only if prescribed by a doctor.
Driving
Caution
Dynaglipt L Tablet has no influence on the ability to drive and use machines. However, dizziness and drowsiness have been reported, which may affect your ability to drive or use machines.
Liver
Caution
If u have or had a history or evidence of any liver-related diseases, please consult the doctor before taking medicine.
Kidney
Caution
If u have or had a history or evidence of any kidney-related diseases, please consult the doctor before taking medicine.
Children
Unsafe
Dynaglipt L Tablet is not recommended for children below the age of 18 years.
Product Substitutes
Uses of Dynaglipt L Tablet
Medicinal Benefits
Dynaglipt L Tablet is primarily used to treat Type 2 diabetes mellitus. It contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Dynaglipt L Tablet is prescribed for type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Dynaglipt L Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis. Thus, Dynaglipt L Tablet plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer and delayed wound healing.
Side Effects of Dynaglipt L Tablet
Directions for Use
Storage
Drug Warnings
Dynaglipt L Tablet should not be taken if you are allergic to Dynaglipt L Tablet or any of its ingredients. Please inform your doctor if you are pregnant or breastfeeding before starting Dynaglipt L Tablet . Prolonged intake of Dynaglipt L Tablet may cause acute pancreatitis (swollen pancreas), and critical kidney problem. Increased risk of hypoglycaemia (low blood sugar level) can occur when Dynaglipt L Tablet is added to other anti-diabetic agents or insulin therapy. In this case, your doctor may adjust the dose of Dynaglipt L Tablet . Severe allergic reactions might occur in some patients taking Dynaglipt L Tablet like anaphylaxis, angioedema (swelling under the skin), and exfoliative skin conditions including Stevens-Johnson syndrome. Safety and efficacy of Dynaglipt L Tablet in children under 18 years have not been established, so it should not be given to them. Patients taking digoxin (a heart medicine) with Dynaglipt L Tablet should be closely monitored as severe drug interaction has been observed. Dynaglipt L Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.
Therapeutic Class
Drug-Drug Interactions
Login/Sign Up
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Diabetes (Type 2): It is a condition where the body cannot make sufficient insulin, or the insulin that it makes doesn't work properly or is utilized by our body. This can cause high blood sugar levels (hyperglycemia). Type 2 diabetes symptoms include increased thirst, frequent urination at night, slow wound healing, increased hunger, fatigue, and blurred vision. There may be weight gain in some cases, while in rare cases, weight loss may be observed. The complication of type 2 diabetes also includes neuropathy (nerve problems), nephropathy (kidney problems), and retinopathy (damaged retina of eyes or blindness), loss of limbs, sexual dysfunction, and increase the chance of heart attack or stroke.
by Others
by Others
by Others
by Others
by Others
Recommended for a 30-day course: 3 Strips